ArticleInvestigational new drugs2012

Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.

Sarah Schott et al.PubMed ↗Publisher ↗

No numbers read from the abstract.